Healthcare
Multiple Sclerosis : what are the exact causes and the future outlooks to treat this disease?
What are the exact causes of multiple sclerosis? What are the future outlooks for the treatment of this disease?
Logbook
Filter:
Healthcare
Natural treatments for atopic dermatitis: new opportunities for pharmaceutical and cosmetic companies
Natural treatments for atopic dermatitis are developing. What opportunities for pharmaceutical and cosmetic companies?
Articles
LFSS: the key measures of the French Social Security Financing Act for the year 2023
The new French Social Security Financing Act was enacted on December 23. What are the key measures of the LFSS in 2023?
Cross-sector
An organic market facing an unprecedented situation
After years of growth, the organic market is running out of steam with a 6.3% drop in sales in 2022. What strategy should be adopted to face this unprecedented situation?
Healthcare
Position Paper Alcimed – Antibiotic resistance: fostering innovation to solve an inevitable problem
How innovation in R&D can help solve the antibiotic resistance issue? What are the stakes for pharma players ? Download our position paper to discover it.
Energy - Environment - Mobility
Wind propulsion: maritime transport is reshaping to adapt to the climate crisis
The climate crisis talks the maritime industry into reinventing itself. What are the issues involved in the diffusion of wind propulsion?
Public policy
How to ensure France’s food sovereignty?
What is the difference between food sovereignty and food self-sufficiency? How to ensure it at the level of French territories?
Healthcare
Drug-resistant epilepsy: what are the alternatives?
How to treat epilepsy refractory to conventional treatments? Discover the existing and emerging therapeutic alternatives.
Healthcare
Molecular pharming: how plant-based pharmaceuticals can revolutionize drug development and manufacturing?
What are the benefits of molecular pharming? Why can plant-based pharmaceuticals be interesting pharmaceutical alternatives? Alcimed explored the potential of molecular pharming to revolutionize drug ...
Cross-sector
Article 51: a unique opportunity to innovate to better support patients
In 2018, the French Social Security Financing Law introduced a mechanism allowing experimentation with new health organizations based on novel financing methods: article 51. This new law article ...